Clinical Trial Update: Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy [Phase 2]

View source ↗

Summary

Open-label extension study evaluating the safety and seizure frequency of lacosamide in people with epilepsy and primary generalized tonic-clonic seizures; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2013-12-04